|
시장보고서
상품코드
2091864
곤충 세포배양 시장 규모, 점유율 및 성장 분석 : 제품별, 용도별, 최종사용자별, 유통경로별, 지역별 - 업계 예측(2026-2033년)Insect Cell Culture Market Size, Share, and Growth Analysis, By Product (Insect Cell Lines (Sf9, Hi5)), By Application, By End-User, By Distribution, By Region - Industry Forecast 2026-2033 |
||||||
세계의 곤충 세포배양 시장 규모는 2024년에 8억 5,000만 달러로 평가되며, 2025년 9억 3,000만 달러에서 2033년까지 19억 5,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 9.62%로 성장할 것으로 전망되고 있습니다.
전 세계 곤충 세포배양 시장은 재조합 단백질, 백신 및 유전자 치료용 벡터 생산에 기여함으로써 인상적인 성장을 달성하고 있습니다. Sf9 및 High-Five와 같은 곤충 세포는 비용 대비 효과를 유지하면서 포유류 시스템을 충실히 재현한 고밀도 배양을 실현합니다. 특히 백신 생산 수요 증가에 대응하기 위한 확장 가능한 바이오 제조에 대한 수요가 높아지면서 시장 확대에 박차를 가하고 있습니다. 개량된 바큐로바이러스 발현 벡터를 통해 곤충 세포배양은 기존 세포주를 대체할 실용적인 대안으로 자리 잡았습니다. 또한 친환경 바이오 공정을 장려하는 규제상의 우대 조치 덕분에 제조업체들은 곤충 기반 시스템을 도입하게 되었으며, 이는 자원 소비와 폐기물 감축으로 이어지고 있습니다. 기업이 곤충 기반 플랫폼을 서비스에 도입함에 따라 자동화 및 고처리량 스크리닝에 대한 투자로 인해 중소 바이오기술 기업의 시장 진입 장벽이 낮아지고 있으며, 치료제, 진단제, 농업용 바이오의약품에 이르는 대상 시장이 확대되고 있습니다.
세계 곤충 세포배양 시장의 성장 요인
전 세계 곤충 세포배양 시장은 기존 포유류 시스템에 비해 단백질 발현 가속화 및 제조 비용 절감 등의 이점을 제공하는 곤충 세포 플랫폼에 대한 기업의 선호도가 높아짐에 따라 성장하고 있습니다. 이러한 효율성 덕분에 시장의 수요에 더욱 민첩하게 대응할 수 있게 되었으며, 새로운 치료제, 백신, 유전자 치료 분야의 혁신이 촉진되고 있습니다. 또한 곤충 세포배양의 확장성이라는 특성은 증가하는 바이오의약품 파이프라인을 보완해 주며, 주요 제조사들이 생산 공정에 이 기술을 도입하도록 유도함으로써 궁극적으로 시장 확대를 지원하고 있습니다. 또한 곤충 세포는 오염 위험이 낮고 배치 주기를 단축할 수 있으며, 생산을 신속하게 확대하는 데 이상적인 선택지입니다.
세계 곤충 세포배양 시장의 제약 요인
전 세계 곤충 세포배양 시장은 곤충 세포 유래 바이오의약품을 둘러싼 규제 체계의 변화에 따라 큰 제약에 직면해 있습니다. 규제 당국은 바이러스성 오염 물질, 특정 당사슬 패턴 및 곤충 유래 단백질의 면역원성에 대한 우려를 완화하기 위해 광범위한 안전성 및 타당성 확인 시험을 종종 요구하므로 제조업체들은 승인 절차와 관련하여 불확실성에 직면해 있습니다. 이러한 불확실성으로 인해 개발 기간이 길어지고 규정 준수 비용이 증가할 가능성이 있으며, 보다 명확한 지침이 제시될 때까지 기업은 곤충 유래 기술에 대한 투자를 주저하거나 축소하게 될 것입니다. 또한 표준화된 테스트 프로토콜이 없기 때문에 개발자는 독자적인 검증 프로세스를 구축할 수밖에 없으며, 그 결과 자원이 소모되고 신제품 출시가 지연됩니다.
세계 곤충 세포배양 시장의 동향
전 세계 곤충 세포배양 시장에서는 친환경 대체품에 대한 소비자 수요가 증가함에 따라 지속가능한 단백질 원료로의 전환이라는 뚜렷한 추세가 나타나고 있습니다. 바이오의약품 기업은 탄소 배출량 저감, 물 소비량 감축, 바이오매스 생산의 확장성 등의 이점을 바탕으로, 기존 포유류 시스템을 대체할 수 있는 재생한 대안으로서 곤충 세포 플랫폼의 가능성을 인식하고, 이를 점점 더 적극적으로 도입하고 있습니다. 이러한 추세는 곤충 유래 기술 제공업체와의 전략적 제휴를 촉진하고, 연구개발에 대한 투자를 지원하고 있습니다. 그 결과, 친환경 제품 파이프라인은 경쟁 우위를 확보해 나가고 있으며, 사회적 책임 투자자들에게 어필하는 동시에 끊임없이 변화하는 시장 상황 속에서 장기적인 생존 가능성을 보장하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 곤충 세포배양 시장 규모 : 제품별
세계의 곤충 세포배양 시장 규모 : 용도별
세계의 곤충 세포배양 시장 규모 : 최종사용자별
세계의 곤충 세포배양 시장 규모 : 유통경로별
세계의 곤충 세포배양 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.27Global Insect Cell Culture Market size was valued at USD 0.85 Billion in 2024 and is poised to grow from USD 0.93 Billion in 2025 to USD 1.95 Billion by 2033, growing at a CAGR of 9.62% during the forecast period (2026-2033).
The global insect cell culture market is experiencing significant growth due to its role in generating recombinant proteins, vaccines, and gene therapy vectors. Insect cells like Sf9 and High-Five offer high-density cultures that closely mimic mammalian systems while maintaining cost-effectiveness. The increasing need for scalable biomanufacturing, particularly in response to heightened vaccine production demands, has fueled market expansion. Enhanced baculovirus expression vectors have established insect cell culture as a viable alternative to traditional cell lines. Additionally, regulatory incentives favoring green bioprocessing have prompted manufacturers to adopt insect systems, reducing resource consumption and waste. As companies integrate insect-based platforms into their services, automation and high-throughput screening investments lower barriers for smaller biotech firms, broadening the addressable market across therapeutics, diagnostics, and agricultural biologics.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insect Cell Culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Insect Cell Culture Market Segments Analysis
Global insect cell culture market is segmented by product, application, end-user, distribution and region. Based on product, the market is segmented into Insect Cell Lines (Sf9, Hi5, Sf21), Baculovirus Expression Vectors and Cell Culture Media & Supplements. Based on application, the market is segmented into Recombinant Protein Production, Baculovirus-Like Particle (VLP) Vaccines and Drug Discovery. Based on end-user, the market is segmented into Pharma & Biotech Companies, Research Institutes and CROs. Based on distribution, the market is segmented into Direct B2B, Distributors and Online. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Insect Cell Culture Market
The Global Insect Cell Culture market is being driven by a growing preference among companies for insect cell platforms, which offer advantages such as accelerated protein expression and reduced manufacturing costs relative to traditional mammalian systems. This efficiency allows for a more agile response to market demands and fosters the innovation of new therapeutics, vaccines, and gene therapies. Furthermore, the scalable nature of insect cell cultures complements the increasing pipeline of biologics, leading manufacturers to adopt this technology in their production processes, thereby fueling market expansion. Additionally, insect cells present a lower risk of contamination and facilitate shorter batch cycles, making them an ideal option for rapid scale-up in production.
Restraints in the Global Insect Cell Culture Market
The Global Insect Cell Culture market faces significant restraints due to the evolving regulatory frameworks surrounding biologics derived from insect cells. Manufacturers encounter ambiguity regarding approval processes, as regulatory agencies often necessitate extensive safety and validation studies to mitigate concerns related to viral contaminants, specific glycosylation patterns, and the immunogenicity of insect-derived proteins. This uncertainty can extend development timelines and inflate compliance costs, causing companies to hesitate or scale back investments in insect-based technologies until more definitive guidelines are presented. Furthermore, the absence of standardized testing protocols compels developers to create custom validation pathways, thereby depleting resources and delaying the launch of new products.
Market Trends of the Global Insect Cell Culture Market
The Global Insect Cell Culture market is witnessing a significant trend towards sustainable protein sources in response to rising consumer demand for environmentally friendly alternatives. Biopharmaceutical companies are increasingly turning to insect cell platforms, recognizing their potential as renewable substitutes for traditional mammalian systems due to their lower carbon footprint, reduced water consumption, and scalability in biomass production. This trend has spurred strategic partnerships with insect-based technology providers, driving investments in research and development. As a result, eco-conscious product pipelines are gaining competitive advantages, appealing to socially responsible investors and ensuring long-term viability in the evolving market landscape.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Insect Cell Culture Market Size by Product & CAGR (2026-2033)
- Market Overview
- Insect Cell Lines (Sf9)
- Hi5
- Sf21
- Baculovirus Expression Vectors
- Cell Culture Media & Supplements
Global Insect Cell Culture Market Size by Application & CAGR (2026-2033)
- Market Overview
- Recombinant Protein Production
- Baculovirus-Like Particle (VLP) Vaccines
- Drug Discovery
Global Insect Cell Culture Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Pharma & Biotech Companies
- Research Institutes
- CROs
Global Insect Cell Culture Market Size by Distribution & CAGR (2026-2033)
- Market Overview
- Direct B2B
- Distributors
- Online
Global Insect Cell Culture Market Size & CAGR (2026-2033)
- North America (Product, Application, End-User, Distribution)
- US
- Canada
- Europe (Product, Application, End-User, Distribution)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Application, End-User, Distribution)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Application, End-User, Distribution)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Application, End-User, Distribution)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Thermo Fisher Scientific (ExpiSf)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Sigma-Aldrich)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Expression Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Expression Systems LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kerafast Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher (Cytiva)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Geneart (Thermo Fisher)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ATUM Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Syngene International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LakePharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Allele Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viral Vectors Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OxGene (Oxford Biomedica)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AccelBio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Applied Biological Materials
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integrated BioTherapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BacVector (Novagen)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
